521 related articles for article (PubMed ID: 18304004)
1. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
Chiu YL; Greene WC
Annu Rev Immunol; 2008; 26():317-53. PubMed ID: 18304004
[TBL] [Abstract][Full Text] [Related]
2. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R; Spadari S; Maga G
Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
Chiu YL; Greene WC
Trends Immunol; 2006 Jun; 27(6):291-7. PubMed ID: 16678488
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
[TBL] [Abstract][Full Text] [Related]
6. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
Wichroski MJ; Robb GB; Rana TM
PLoS Pathog; 2006 May; 2(5):e41. PubMed ID: 16699599
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
Esnault C; Heidmann O; Delebecque F; Dewannieux M; Ribet D; Hance AJ; Heidmann T; Schwartz O
Nature; 2005 Jan; 433(7024):430-3. PubMed ID: 15674295
[TBL] [Abstract][Full Text] [Related]
8. The viral infectivity factor (Vif) of HIV-1 unveiled.
Rose KM; Marin M; Kozak SL; Kabat D
Trends Mol Med; 2004 Jun; 10(6):291-7. PubMed ID: 15177194
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances in the study of mechanism of APOBEC3G against virus].
Zhu YP; Jiang JD; Peng ZG
Yao Xue Xue Bao; 2014 Jan; 49(1):30-6. PubMed ID: 24783502
[TBL] [Abstract][Full Text] [Related]
10. APOBEC-mediated viral restriction: not simply editing?
Holmes RK; Malim MH; Bishop KN
Trends Biochem Sci; 2007 Mar; 32(3):118-28. PubMed ID: 17303427
[TBL] [Abstract][Full Text] [Related]
11. Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.
Izumi T; Shirakawa K; Takaori-Kondo A
Mini Rev Med Chem; 2008 Mar; 8(3):231-8. PubMed ID: 18336343
[TBL] [Abstract][Full Text] [Related]
12. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
[TBL] [Abstract][Full Text] [Related]
13. Virology. Weapons of mutational destruction.
KewalRamani VN; Coffin JM
Science; 2003 Aug; 301(5635):923-5. PubMed ID: 12920286
[No Abstract] [Full Text] [Related]
14. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses.
Esnault C; Millet J; Schwartz O; Heidmann T
Nucleic Acids Res; 2006; 34(5):1522-31. PubMed ID: 16537839
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vif: counteracting innate antiretroviral defenses.
Cullen BR
Mol Ther; 2003 Oct; 8(4):525-7. PubMed ID: 14565218
[No Abstract] [Full Text] [Related]
16. New insights into the role of Vif in HIV-1 replication.
Schröfelbauer B; Yu Q; Landau NR
AIDS Rev; 2004; 6(1):34-9. PubMed ID: 15168739
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into HIV-1 Vif.
Navarro F; Landau NR
Curr Opin Immunol; 2004 Aug; 16(4):477-82. PubMed ID: 15245742
[TBL] [Abstract][Full Text] [Related]
18. Retroviral restriction by APOBEC proteins.
Harris RS; Liddament MT
Nat Rev Immunol; 2004 Nov; 4(11):868-77. PubMed ID: 15516966
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3G & HTLV-1: inhibition without deamination.
Strebel K
Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
[TBL] [Abstract][Full Text] [Related]
20. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
Russell RA; Wiegand HL; Moore MD; Schäfer A; McClure MO; Cullen BR
J Virol; 2005 Jul; 79(14):8724-31. PubMed ID: 15994766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
